Cargando…
Spinal muscular atrophy type I associated with a novel SMN1 splicing variant that disrupts the expression of the functional transcript
INTRODUCTION: Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by pathogenic variants in the SMN1 gene. The majority of SMA patients harbor a homozygous deletion of SMN1 exon 7 (95%). Heterozygosity for a conventional variant and a deletion is rare (5%) and not e...
Autores principales: | Votsi, Christina, Koutsou, Pantelitsa, Ververis, Antonis, Georghiou, Anthi, Nicolaou, Paschalis, Tanteles, George, Christodoulou, Kyproula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548546/ https://www.ncbi.nlm.nih.gov/pubmed/37799281 http://dx.doi.org/10.3389/fneur.2023.1241195 |
Ejemplares similares
-
A novel c.5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia
por: Nicolaou, Paschalis, et al.
Publicado: (2008) -
The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
por: Hensel, Niko, et al.
Publicado: (2020) -
A Novel SPG7 Gene Pathogenic Variant in a Cypriot Family With Autosomal Recessive Spastic Ataxia
por: Votsi, Christina, et al.
Publicado: (2022) -
The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p.P600R substitution causes demyelinating Charcot–Marie–Tooth disease
por: Cinarli Yuksel, Feride, et al.
Publicado: (2023) -
A Novel CLN6 Variant Associated With Juvenile Neuronal Ceroid Lipofuscinosis in Patients With Absence of Visual Loss as a Presenting Feature
por: Nicolaou, Paschalis, et al.
Publicado: (2021)